Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. CAR T-Cell therapy Market, by Region, 2020-2030 (USD Billion)
1.2.2. CAR T-Cell therapy Market, by Indication, 2020-2030 (USD Billion)
1.2.3. CAR T-Cell therapy Market, by Drug type, 2020-2030 (USD Billion)
1.2.4. CAR T-Cell therapy Market, by End user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global CAR T-Cell therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global CAR T-Cell therapy Market Dynamics
3.1. CAR T-Cell therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the incidence of cancer such as leukemia and lymphoma
3.1.1.2. Favorable reimbursement policies for CAR T-cell therapy medications
3.1.2. Market Challenges
3.1.2.1. Unavailability of skilled professionals
3.1.2.2. High cost of developing CAR T-cell therapy
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research and development
3.1.3.2. Increasing advancements in technology
Chapter 4. Global CAR T-Cell therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global CAR T-Cell therapy Market, by Indication
5.1. Market Snapshot
5.2. Global CAR T-Cell therapy Market by Indication, Performance – Potential Analysis
5.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. CAR T-Cell therapy Market, Sub Segment Analysis
5.4.1. Lymphoma
5.4.2. Acute Lymphocytic Leukemia
5.4.3. Others
Chapter 6. Global CAR T-Cell therapy Market, by Drug type
6.1. Market Snapshot
6.2. Global CAR T-Cell therapy Market by Drug type, Performance – Potential Analysis
6.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Drug type 2020-2030 (USD Billion)
6.4. CAR T-Cell therapy Market, Sub Segment Analysis
6.4.1. Axicabtagene Ciloleucel
6.4.2. Tisagenlecleucel
6.4.3. Brexucabtagene Autoleucel
6.4.4. Others
Chapter 7. Global CAR T-Cell therapy Market, by End user
7.1. Market Snapshot
7.2. Global CAR T-Cell therapy Market by End user, Performance – Potential Analysis
7.3. Global CAR T-Cell therapy Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
7.4. CAR T-Cell therapy Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Cancer Treatment Centers
Chapter 8. Global CAR T-Cell therapy Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. CAR T-Cell therapy Market, Regional Market Snapshot
8.4. North America CAR T-Cell therapy Market
8.4.1. U.S. CAR T-Cell therapy Market
8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
8.4.1.2. Drug type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
8.4.2. Canada CAR T-Cell therapy Market
8.5. Europe CAR T-Cell therapy Market Snapshot
8.5.1. U.K. CAR T-Cell therapy Market
8.5.2. Germany CAR T-Cell therapy Market
8.5.3. France CAR T-Cell therapy Market
8.5.4. Spain CAR T-Cell therapy Market
8.5.5. Italy CAR T-Cell therapy Market
8.5.6. Rest of Europe CAR T-Cell therapy Market
8.6. Asia-Pacific CAR T-Cell therapy Market Snapshot
8.6.1. China CAR T-Cell therapy Market
8.6.2. India CAR T-Cell therapy Market
8.6.3. Japan CAR T-Cell therapy Market
8.6.4. Australia CAR T-Cell therapy Market
8.6.5. South Korea CAR T-Cell therapy Market
8.6.6. Rest of Asia Pacific CAR T-Cell therapy Market
8.7. Latin America CAR T-Cell therapy Market Snapshot
8.7.1. Brazil CAR T-Cell therapy Market
8.7.2. Mexico CAR T-Cell therapy Market
8.8. Middle East & Africa CAR T-Cell therapy Market
8.8.1. Saudi Arabia CAR T-Cell therapy Market
8.8.2. South Africa CAR T-Cell therapy Market
8.8.3. Rest of Middle East & Africa CAR T-Cell therapy Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Autolus Therapeutics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bluebird bio, Inc.
9.3.3. Bristol-Myers Squibb
9.3.4. Caribou Biosciences, Inc.
9.3.5. Cartesian Therapeutics, Inc.
9.3.6. Celgene Corporation
9.3.7. Gilead Sciences, Inc. (Kite Pharma Inc.)
9.3.8. Merck & Co., Inc.
9.3.9. Novartis AG
9.3.10. Pfizer, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
